# name
Delayed haemolysis after artesunate therapy in a cohort of
                patients with severe imported malaria due to Plasmodium
                falciparum

# metadata.dc.description.abstract[].value
INTRODUCTION: Delayed haemolytic anaemia is one of the more
                frequent events after treatment with intravenous artesunate in
                patients with severe malaria. Little is known about its
                frequency and the outcomes of patients with this condition.
                METHODS: A retrospective study was conducted to describe the
                incidence of delayed haemolysis in a cohort of patients with
                severe malaria by Plasmodium falciparum treated with artesunate
                between August 2013 and July 2015. RESULTS: The study included
                52 patients with malaria due to Plasmodium falciparum, with 21
                having severe malaria. The majority were male (66.7%), and the
                median age was 43 years. Four patients (19%) presented
                post-artesunate delayed haemolysis 11-13 days from the
                initiation of treatment. Two patients required hospital
                admission and red blood cell transfusion. CONCLUSION:
                Post-artesunate delayed haemolysis is frequent in patients with
                severe malaria treated with intravenous artemisinins. These
                patients should be monitored for 4 weeks after treatment is
                started.

# metadata.dc.relation.isformatof[].value
Versió postprint del document publicat a:
                http://dx.doi.org/10.1016/j.eimc.2015.11.003

# metadata.dc.relation.ispartof[].value
Enfermedades Infecciosas y Microbiologia Clinica, 2016

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
Delayed haemolysis after artesunate therapy in a cohort of
                patients with severe imported malaria due to Plasmodium
                falciparum